ADC图影像组学模型诊断头颈部鳞癌局部复发
本研究回顾性纳入285例根治性治疗后MRI出现强化病灶的头颈部鳞癌患者,基于ADC图、T2WI和CE-T1WI构建影像组学模型。ADC组学评分在内外部验证集AUROC分别为0.76和0.77,外部验证中显著高于T2WI、CE-T1WI及临床参数(均0.53)。
要点
- ADC图影像组学模型诊断局部复发的性能优于T2WI和CE-T1WI。
- 外部验证ADC组学评分AUROC为0.77,临床参数仅0.53。
- 对根治后随访MRI新出现强化病灶,ADC组学有助鉴别复发。
核心结论
- 基于ADC图的影像组学模型在诊断HNSCC根治性治疗后局部肿瘤复发方面,诊断性能高于T2WI、CE-T1WI影像组学模型及临床参数。
研究设计与样本
- 回顾性研究纳入285例根治性治疗后随访MRI出现原发部位新发对比增强病灶的HNSCC患者,平均年龄62±12岁,男性220例(77.2%)。
- 215例用于训练(n=161)和内部验证(n=54),另70例用于外部验证;训练集和外部验证集中分别有127例和34例局部复发。
- 基于T2WI、CE-T1WI和ADC图分别构建影像组学模型,采用LASSO非零系数筛选特征,以ROC分析评估诊断性能。
诊断标准与关键数值
- ADC图影像组学评分内部验证集AUROC为0.76(95%CI 0.62-0.89),外部验证集为0.77(95%CI 0.65-0.88)。
- 外部验证集中ADC组学评分AUROC显著高于T2WI(0.53,95%CI 0.40-0.67,p=0.006)、CE-T1WI(0.53,95%CI 0.40-0.67,p=0.012)和临床参数(0.53,95%CI 0.39-0.67,p=0.021)。
- T2WI模型选用5个影像组学特征,CE-T1WI模型选用6个,ADC图模型选用9个。
临床应用与阅片要点
- 对HNSCC根治性治疗后随访MRI新出现对比增强病灶,可借助ADC图影像组学评分辅助鉴别局部复发。
- ADC图影像组学诊断性能优于常规T2WI和CE-T1WI,阅片时可关注ADC图纹理特征。
局限性
- 本研究为回顾性设计。
- 外部验证集样本量较小(70例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop and validate a model using radiomics features from apparent diffusion coefficient (ADC) map to diagnose local tumor recurrence in head and neck squamous cell carcinoma (HNSCC).
MATERIALS AND METHODS: This retrospective study included 285 patients (mean age ± standard deviation, 62 ± 12 years; 220 male, 77.2%), including 215 for training (n = 161) and internal validation (n = 54) and 70 others for external validation, with newly developed contrast-enhancing lesions at the primary cancer site on the surveillance MRI following definitive treatment of HNSCC between January 2014 and October 2019. Of the 215 and 70 patients, 127 and 34, respectively, had local tumor recurrence. Radiomics models using radiomics scores were created separately for T2-weighted imaging (T2WI), contrast-enhanced T1-weighted imaging (CE-T1WI), and ADC maps using non-zero coefficients from the least absolute shrinkage and selection operator in the training set. Receiver operating characteristic (ROC) analysis was used to evaluate the diagnostic performance of each radiomics score and known clinical parameter (age, sex, and clinical stage) in the internal and external validation sets.
RESULTS: Five radiomics features from T2WI, six from CE-T1WI, and nine from ADC maps were selected and used to develop the respective radiomics models. The area under ROC curve (AUROC) of ADC radiomics score was 0.76 (95% confidence interval [CI], 0.62-0.89) and 0.77 (95% CI, 0.65-0.88) in the internal and external validation sets, respectively. These were significantly higher than the AUROC values of T2WI (0.53 [95% CI, 0.40-0.67], p = 0.006), CE-T1WI (0.53 [95% CI, 0.40-0.67], p = 0.012), and clinical parameters (0.53 [95% CI, 0.39-0.67], p = 0.021) in the external validation set.
CONCLUSION: The radiomics model using ADC maps exhibited higher diagnostic performance than those of the radiomics models using T2WI or CE-T1WI and clinical parameters in the diagnosis of local tumor recurrence in HNSCC following definitive treatment.
引用
- Kim, Lee, Joo, et al. Development and Validation of a Model Using Radiomics Features from an Apparent Diffusion Coefficient Map to Diagnose Local Tumor Recurrence in Patients Treated for Head and Neck Squamous Cell Carcinoma. Korean J Radiol. 2022. PMID: 36126954. doi:10.3348/kjr.2022.0299
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。